Quince Therapeutics, Inc.

Form D Filings

Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001662774
Previous Names
Quince Therapeutics, Inc., Cortexyme, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
7/1/2025 Equity, Option to Acquire, Security to be Acquired $11,488,304 $21,896,618 $10,408,314 6/18/2025 7/1/2025 D 000166277425000035
5/31/2018 Equity $84,466,700 $85,566,697 $1,099,997 5/23/2018 5/31/2018 D 000166277418000001
2/14/2017 Debt $7,600,000 $8,000,000 $400,000 2/1/2017 2/14/2017 D 000166277417000001
1/5/2016 Equity $7,918,642 $15,918,641 $7,999,999 12/22/2015 1/5/2016 D 000166277416000002